Clinical Trial Update: IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing IV or IV/PO omadacycline to IV/PO levofloxacin for acute pyelonephritis completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pyelonephritis

Drugs mentioned

• Levofloxacin (Levofloxacin)
• Omadacycline (omadacycline)

Snippet

Sponsor: Paratek Pharmaceuticals Inc | Conditions: Acute Pyelonephritis | Phase 2 | Status: COMPLETED | Results posted: 2020-07-07